Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Late-onset hypogonadism: reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Sesti, F.; Pofi, R.; Minnetti, M.; Tenuta, M.; Gianfrilli, D.; Isidori, A. M.
    • بيانات النشر:
      Blackwell Publishing Ltd
    • الموضوع:
      2020
    • Collection:
      Sapienza Università di Roma: CINECA IRIS
    • نبذة مختصرة :
      Background: Low testosterone (T) level is considered a marker of poor cardiovascular health. Ten years ago, the Testosterone in Older Men with Mobility Limitations (TOM) trial was discontinued due to a higher number of adverse events in men receiving T compared with placebo. Since then, several studies have investigated the risks of T replacement therapy (TRT) in late-onset hypogonadism (LOH). Objective: To review the mechanism by which TRT could damage the cardiovascular system. Materials and methods: Comprehensive literature search of recent clinical and experimental studies. Results: The mechanisms of T-mediated coronary vasodilation were reviewed with emphasis on calcium-activated and ATP-sensitive potassium ion channels. We showed how T regulates endothelial nitric oxide synthase (eNOS) and phosphoinositide 3-kinase/protein kinase B/eNOS signaling pathways in vessel walls and its direct effects on cardiomyocytes via β1-adrenergic and ryanodine receptors and provided data on myocardial infarction and heart failure. Vascular smooth muscle senescence could be explained by the modulation of growth factors, matrix metalloproteinase-2, and angiotensin II by T. Furthermore, leukocyte trafficking, facilitated by changes in TNF-α, could explain some of the effects of T on atheromatous plaques. Conflicting data on prothrombotic risk linked to platelet aggregation inhibition via NO-triggered arachidonate synthesis or increased aggregability due to enhanced thromboxane A in human platelets provide evidence regarding the hypotheses on plaque maturation and rupture risk. The effects of T on cardiac electrophysiology and oxygen delivery were also reviewed. Discussion: The effects of TRT on the cardiovascular system are complex. Although molecular studies suggest a potential benefit, several clinical observations reveal neutral or occasionally detrimental effects, mostly due to confounding factors. Conclusions: Attempts to demonstrate that TRT damages the cardiovascular system via systematic analysis of the putative ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/32737921; info:eu-repo/semantics/altIdentifier/wos/WOS:000558210000001; volume:8; issue:6; firstpage:1614; lastpage:1627; numberofpages:14; journal:ANDROLOGY; http://hdl.handle.net/11573/1555386; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089291841
    • الرقم المعرف:
      10.1111/andr.12876
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.4E83BCB5